Islet Management’s TriSalus Life Sciences TLSI Stock Holding History

Islet Management’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-163,979	Closed	-$134K	–	258
2021 Q3	$134K	Buy	+163,979	New	+$1.61M	﹤0.01%	194

Other funds holding TLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Islet Management's TLSI Position: Q4 2021 in Review

Islet Management sold out of TriSalus Life Sciences (TLSI) in Q4 2021, closing a stake of 491,940 shares — an estimated $4.88M sold.

Islet Management first reported a position in TLSI in Q3 2021 and held it in 1 quarter. The position peaked at $4.88M in Q3 2021. 68 funds tracked by Wall St. Rank hold TLSI as of Q4 2021.

Islet Management reported no remaining TriSalus Life Sciences position as of Q4 2021 after selling out during the quarter.
Islet Management sold 491,940 TriSalus Life Sciences shares in Q4 2021, an estimated $4.88M.
Islet Management first reported a position in TriSalus Life Sciences in Q3 2021 and held it in 1 quarter.
Islet Management's TriSalus Life Sciences position peaked at $4.88M in Q3 2021.
68 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2021.

Based on Islet Management's 13F filing for Q4 2021, filed 14 Feb 2022.